CG
TVRD

Cutler Group’s Tvardi Therapeutics TVRD Stock Holding History

Cutler Group’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11
Closed -$1K – 6223
2021
Q4 		$1K Buy
+11
New +$5.53K ﹤0.01% 5211
2021
Q3 		– Sell
-36
Closed -$3K – 6508
2021
Q2 		$3K Buy
+36
New +$22.8K ﹤0.01% 4866
2020
Q3 		– Sell
-111
Closed -$16K – 5356
2020
Q2 		$16K Hold
111
– – ﹤0.01% 2562
2020
Q1 		$32K Buy
+111
New +$60.3K ﹤0.01% 2020
2019
Q3 		– Sell
-708
Closed -$3K – 4832
2019
Q2 		$3K Buy
+708
New +$497K ﹤0.01% 3443
2018
Q4 		– Sell
-25
Closed -$1K – 4718
2018
Q3 		$1K Sell
25
-197
-89% -$142K ﹤0.01% 3917
2018
Q2 		$5K Buy
222
+194
+693% +$98.6K ﹤0.01% 3162
2018
Q1 		$8K Sell
28
-136
-83% -$66K ﹤0.01% 2989
2017
Q4 		$28K Sell
164
-122
-43% -$55.6K ﹤0.01% 2301
2017
Q3 		$22K Sell
286
-2,783
-91% -$1.39M ﹤0.01% 3058
2017
Q2 		$245K Buy
3,069
+1,119
+57% +$710K 0.01% 1133
2017
Q1 		$46K Buy
1,950
+1,769
+977% +$945K ﹤0.01% 2502
2016
Q4 		$4K Buy
181
+87
+93% +$27.9K ﹤0.01% 5164
2016
Q3 		$1K Sell
94
-17
-15% -$3.68K ﹤0.01% 6354
2016
Q2 		$5K Sell
111
-58
-34% -$12.6K ﹤0.01% 4997
2016
Q1 		$1K Buy
169
+125
+284% +$37.3K ﹤0.01% 6190
2015
Q4 		$6K Buy
+44
New +$24.2K ﹤0.01% 4758

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's TVRD Position: Q1 2023 in Review

Cutler Group sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 17 shares — an estimated $6K sold.

Cutler Group first reported a position in TVRD in Q4 2015 and held it in 24 quarters. The position peaked at $316K in Q1 2017. 162 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.

  • Cutler Group reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 17 Tvardi Therapeutics shares in Q1 2023, an estimated $6K.
  • Cutler Group first reported a position in Tvardi Therapeutics in Q4 2015 and held it in 24 quarters.
  • Cutler Group's Tvardi Therapeutics position peaked at $316K in Q1 2017.
  • 162 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.